Skip to main content
Back to Qiming Venture Partners

Qiming Venture Partners's Biotechnology Portfolio

Browse 84 Biotechnology companies funded by Qiming Venture Partners. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
84
Total Funding in Biotechnology
$5.1B

Biotechnology Portfolio Companies (84)

Export
BiotechnologyHealth CarePharmaceutical

AskGene Pharma is a pharmaceuticals company.

Camarillo, United States
July 2023
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.

Berkeley, United States
July 2025
$54.5M
Seed

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceOncologyPharmaceuticalPrecision Medicine

Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.

New York, United States
June 2023
$50.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife ScienceMedical

Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function.

Watertown, United States
June 2026
$10.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.

Amsterdam, The Netherlands
June 2026
$45.4M
Undisclosed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.

San Francisco, United States
May 2026
$38.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedical

Windward Bio develops monoclonal antibodies for advanced immunological diseases.

Basel, Switzerland
May 2026
$165.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyPharmaceutical

Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.

Laguna Hills, United States
April 2026
$35.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Vivatides Therapeutics develops RNA treatments to help improve patients' lives using biotechnology research.

Woburn, United States
April 2026
$54.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareOncologyPharmaceutical

Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.

Cambridge, United States
March 2026
$75.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedicalTherapeutics

Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.

Doylestown, United States
March 2026
$89.0M
Series B

Founder Contacts

30,000+ verified contacts

Biotechnology

Immutrin is a biotech developing next‑generation antibody therapies to clear amyloid deposits and reverse amyloidosis.

Cambridge, United Kingdom
March 2026
$87.1M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyProduct ResearchTherapeutics

Candid Therapeutics develops therapies for autoimmune diseases using antibody-based technologies that modulate immune system activity.

San Diego, United States
March 2026
$505.0M
Undisclosed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalPharmaceutical

Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.

Boston, United States
March 2024
$47.1M
Series F

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CarePharmaceutical

Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.

Cambridge, United States
March 2025
$123.0M
Series E

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical

AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.

Foster City, United States
September 2025
$63.0M
Series B

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMedicalNeuroscience

Fasikl is a neuro-AI company that creates interfaces for the nervous system.

Bloomington, United States
September 2025
$26.6M
Series B

Founder Contacts

30,000+ verified contacts

Biotechnology

Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders

San Francisco, United States
September 2025
$65.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

Seattle, United States
August 2024
$144.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsPharmaceuticalTherapeutics

GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.

South San Francisco, United States
January 2024
$24.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsMedical

Complete Omics is a developer of multi-omics diagnostics for early disease detection.

Baltimore, United States
November 2023
$10.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsLife ScienceOncology

Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.

Vancouver, Canada
April 2023
$142.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsHospitalMedicalmHealthWellness

LetsGetChecked is an at-home health testing platform that connects customers to regulated laboratory testing.

Atlanta, United States
January 2025
$165.0M
Series F

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceuticalProduct Research

Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.

South San Francisco, United States
December 2025
$747.5M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical

Sinogen Biopharma is a developer of innovative drugs with a vision to bridge China's biotech innovation to the US pharma market.

Boston, United States
December 2023
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyEdiscoveryLife ScienceProduct Research

Platelet Biogenesis is an allogeneic cell therapy company that focuses on platelet biology.

Watertown, United States
November 2021
$75.5M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsMedicalmHealthTherapeutics

Caidya is a clinical research organization that provides personalized solutions for various therapeutic areas.

Raleigh, United States
January 2025
$165.0M
Private Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical

Powering precision proteomics to enable to the earliest detection of disease.

Fremont, United States
January 2026
$50.0M
Convertible Note

Founder Contacts

30,000+ verified contacts

Alternative ProteinArtificial Intelligence (AI)BiotechnologyConsultingEnergy EfficiencyMedical

Tianhu Technology is a computational chemistry and AI-driven innovative drug molecule design provider.

Minhang, China
March 2026
$29.0M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedical

CSR Biotech is a biological research company that provides cell imaging and data processing services.

Haidian, China
March 2026
Series B

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiopharmaBiotechnologyGeneticsNanotechnologyPharmaceuticalTherapeutics

BreezeBio is a biotechnology business that creates genetic therapies using precision, non-viral delivery across clinically important tissues

Brisbane, United States
February 2026
$60.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

GluBio Therapeutics engages in molecular glue-targeted protein degradation drug discovery.

Hangzhou, China
February 2026
$30.0M
Corporate Round

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments.

Minhang, China
January 2026
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceutical

Zenitar is a biomedical technology company engaged in innovative drug research and industrialization processes.

Chengdu, China
January 2026
$86.0M
Series C

Founder Contacts

30,000+ verified contacts

BioinformaticsBiotechnologyIndustrial AutomationManufacturingProduct Research

PRCXI Biotechnology is a biotech company that focuses on analytical instruments, bioinformatics and automation solutions for life sciences.

Suzhou, China
December 2025
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Oukejian specializes in researching and developing innovative large-molecule drugs for prevalent fundus diseases.

Nanshan, China
December 2025
$30.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyManufacturingPharmaceutical

Convergen develops TrimTAC, a targeted protein degradation platform for treating neurodegenerative diseases.

Suzhou, China
December 2025
$10.0M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

ChemLex is a chemical synthesis CRO that was founded by Magera Technology.

Shanghai, China
December 2025
$45.0M
Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalOncologyPharmaceuticalTherapeutics

Vybio is a high-tech enterprise focusing on innovative drug research and development.

Hangzhou, China
November 2025
$14.1M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyMedical

TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure.

Shanghai, China
November 2025
$22.0M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Brise Pharma operates in the scientific research and technical service industry.

Shanghai, China
November 2025
$28.1M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalTherapeutics

Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the regulation of epigenetic mechanisms.

Shanghai, China
September 2025
$60.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsGenetics

GenEditBio is a biotech company that specializes in providing curative gene editing based solutions for genetic diseases.

Beijing, China
August 2025
Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .

Beijing, China
August 2025
$12.7M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceuticalProduct ResearchTherapeutics

Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.

Shanghai, China
August 2025
$131.0M
Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth DiagnosticsTherapeutics

Simaixu Biotechnology is a biopharmaceutical firm that develop small molecule drugs for cancer, and chronic diseases with new technologies

Suzhou, China
July 2025
$1.6M
Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.

Newton, United States
July 2025
Series Unknown

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedical

Tianchen Biotechnology is a biotech company that specializes in the development and sales of ophthalmology-related medical products.

Tianjin, China
June 2025
$27.8M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalPharmaceutical

LongBio Pharma is a biotech company that treats patients with an emphasis on complement and allergy diseases.

Pudong, China
May 2025
$28.9M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedical

Yuyao Bio is an innovative drug research and development company.

Shanghai, China
April 2025
$71.3M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyMachinery ManufacturingTest and Measurement

Inces is a biotech enterprise focusing on bio-separation technology.

Nanjing, China
January 2025
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Tachem is a research and development manufacturer of protected amino acid series products.

Zigong, China
September 2024
$9.3M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife Science

Chenzhang Bio is a biotechnology developer specializing in stem cell storage and treatment technology.

Chongqing, China
August 2024
$2.8M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyPharmaceuticalProduct ResearchTherapeutics

Novamab focuses on the research and development of new nanobodies.

Shanghai, China
July 2024
$24.4M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyIndustrialInnovation Management

Jiakekangnuo Bio focuse on technology, promote industrial incubation through strategic investment, and achieves commercialization.

Fengxian, China
April 2024
$6.9M
Angel

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth Care

Cure Genetics is a biotechnology company that develops innovative medicines & molecular diagnostics to treat cancers & genetic diseases.

Suzhou, China
March 2024
$9.0M
Series B

Founder Contacts

30,000+ verified contacts

AgricultureBiotechnologyChemical Engineering

Silicon Yi Technology is a biotech firm specializing in RNA nanopesticide research and development designed to target pests and diseases.

Shanghai, China
February 2024
$4.2M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsTherapeutics

Tourmaline Bio is a biotechnology company that develops medicines to treat inflammatory and immune diseases in patients.

New York, United States
January 2024
$172.5M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CarePharmaceutical

KeChow Pharma, Inc. is a biopharmaceutical company focused on novel drug discovery.

Pudong, China
November 2023
Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHardwareHealth CareInformation TechnologySemiconductorSensor

Onechip Bioelectronics develops biosensor chips and nanomaterials.

Zhangjiagang, China
September 2023
$13.7M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth Care

Vongi provide medical solution design and product design.

Hangzhou, China
March 2023
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalMedical Device

Newsoara is a biomedical technology developer that specializes in the development of medical devices.

Shanghai, China
December 2022
Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth Care

PlusLife Biotech is driven to creating newer molecular diagnostic tools using a new generation of genetic technologies.

Guangzhou, China
October 2022
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyManufacturingPharmaceutical

Zhenge Biotech is a macromolecular pharmaceutical contract development and manufacturing organisation.

Shanghai, China
August 2022
$14.7M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth Diagnostics

Gaugene provides hematology testing instruments, reagents, and services for IVD users.

Beijing, China
July 2022
$14.8M
Series B

Founder Contacts

30,000+ verified contacts

Biotechnology

Ashermed is an CRO company that provides clinical research for pharmaceutical and device companies.

Shanghai, China
May 2022
$14.9M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHospitalManufacturingMedical Device

Wuxi Vision Pro is an emerging in ophthalmic materials and devices.

Wuxi, China
May 2022
$8.0M
Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsCollaborationManufacturingMarket ResearchMedicalPrecision Medicine

Belief BioMed focuses on gene therapy R&D, manufacturing, and clinical applications, specializing in novel AAV vectors.

Minhang, China
April 2022
$120.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsTherapeutics

Medilink Therapeutics is a biotech company focusing on next-generation antibody-drug conjugate Research & development.

Suzhou, China
March 2022
$70.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Abogen Biosciences is a clinical stage biotechnology company focuses on developing nucleic acid-based RNA therapeutics.

Suzhou, China
November 2021
$300.0M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Genevide is a biotech company that specializes in gene research and development.

Suzhou, China
September 2021
$6.0M
Angel

Founder Contacts

30,000+ verified contacts

Biotechnology

Zion Pharma is a drug discovery platform.

Shanghai, China
July 2021
$40.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalMedical Device

Health Biotech is a mass spec research and development company.

Changping, China
May 2021
$31.1M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsLife ScienceTherapeutics

Basecamp Bio develops cell and gene therapies, regenerative medicine, and immunotherapies.

Waltham, United States
March 2021
$14.0M
Angel

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Kira Pharmaceuticals is a Biotechnology Research Company.

Hong Kong, Hong Kong
January 2021
$53.5M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Asieris Pharmaceuticals is a Chinese biotech company.

Shanghai, China
November 2020
$105.6M
Series D

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.

Shanghai, China
September 2020
$147.0M
Series D

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife SciencePharmaceutical

Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.

Shanghai, China
July 2020
$97.0M
Series C

Founder Contacts

30,000+ verified contacts

Big DataBiotechnologyHealth CareMedical

New Horizon Health is a bio-tech company focusing on early screening and genetic testing services for high-incidence cancer homes.

Hangzhou, China
July 2020
$30.0M
Series E

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical

Berry Genomics is a company specializing in developing and commercializing technologies for life sciences and clinical applications.

Beijing, China
March 2020
$10.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth DiagnosticsMedical

JFK Biotech produces and sells molecular diagnostic products for cancer.

Hangzhou, China
April 2018
$1.6M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical Device

ARMO Biosciences is a biotechnology company that develops immune modulatory biologic therapeutics.

Redwood City, United States
January 2018
Series Unknown

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CarePharmaceuticalPrecision Medicine

Qiagen Suzhou Translational Medicine is a precision medicine solutions provider that provides pharmaceutical supply chain services.

Suzhou, China
July 2017
$25.7M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyDelivery ServiceHealth CareLife Science

BBI Life Sciences Corporation providers the life sciences research products and services industry.

Shanghai, China
March 2015
$10.3M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

Explore Qiming Venture Partners's Full Portfolio

View all companies funded by Qiming Venture Partners across every industry and funding stage.

View Full Qiming Venture Partners Portfolio